{"transactions":[{"id":2210982,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":125539,"kind":"person","name":"Chen Robert C J","position":1,"cik":"0001931826","reported_name":"Chen Robert C J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Options","published_at":"2022-07-07T20:53:00.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":900000,"price":0.04,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options were awarded by the Board of Directions as part of Mr. Chen's employment agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on May 16, 2023."}],"balance_after":900000,"derivative":{"exercise_price":0.04,"exercise_date":"2023-05-16","expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001931826-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000193182622000002/primary_doc.xml","form_type":"4"}}]}